A single-blind study compared the clinical efficacy of biperiden hydrochloride (Akineton®, Abbott) and benzhexol (Artane®, Lederle) in the treatment of neuroleptic-induced Parkinsonism. Both drugs were highly effective and all patients responded favourably to medication. No significant difference was observed between the two treatment groups when individual symptoms were examined.
Get full access to this article
View all access options for this article.
References
1.
AydF J (1960) Drug-induced extrapyramidal reactions: their clinical manifestations and treatment with Akineton. Psychosomatics1, 143.
2.
AydF J (1961) A survey of drug-induced extrapyramidal reactions. Journal of the American Medical Association175, 1054.
3.
BrandtWBrandtG (1956) Treatment of the Parkinsonian Syndrome. Deutsche Medizinische Wochenschrift81, 1013.
4.
KlineN S (1974) Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonism agent. Current Therapeutic Research16, 838.
5.
SalzbergerG J (1966) Clinical use of biperiden in the treatment of postencephalitic and drug induced Parkinsonism. Clinical Medicine73, 71.
6.
SchwartzDSiebenhaarC (1955) A new medical treatment of Parkinsonism. Medizinische Klinik50, 1473.
